Pre-eclampsia test (PE)
Product introduction
cell-free RNA (cfRNA) in blood and DNA methylation are combined with AI intelligence to predict the possibility of preeclampsia in early pregnancy, to guide the clinical treatment for prevention.
Product advantages
Precision——combined with artificial intelligence for more accurate prediction
Advance——brought forward to 16th week or even earlier
Applicable population
all women in early pregnancy
Service process
prenatal counseling
identify the clinical indications
sample collection
4ml of whole blood，
and plasma was isolated by centrifugation
sample transport
cold chain transport at -80°C
full range temperature monitoring
pre-eclampsia testing
15 workdays
detection report
predicts possibility of pre-eclamsia
